Salivary Gland Carcinoma — Trials

Salivary Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–28 of 28 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04858334	APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation	recruiting	Phase 2	152	National Cancer Institute (NCI)NIH	3	Sep 25, 2026	clinicaltrials
NCT06781567	Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma(HG146)	recruiting	Phase 2	140	HitGen Inc.INDUSTRY	1	Sep 21, 2026